Unilife started life in 2002 as a small Australian company with two inventors, one CEO and a grand vision.

Following the signing of the Exclusive agreement with sanofi-aventis in July 2008, the Company began to transition key commercial and operational functions from Sydney to the FDA-registered facilities of its wholly-owned U.S. subsidiary Integrated BioSciences Inc (IBS) situated in Lewisberry, Pennsylvania. This included the relocation of Chief Executive Officer Alan Shortall and a small number of other executives to Central Pennsylvania to help establish this facility as Unilife’s global headquarters.

Unilife subsequently commenced a significant recruitment program to fill a number of key management positions at its Pennsylvania facility which were necessary to support the future corporate and operational requirements of the Company. This included the appointment of Bernhard Opitz as Senior Vice President of Operations, Mark Iampietro as Vice-President of Quality and Regulatory Affairs and Dan Calvert as the new U.S.-based CFO of Unilife. Each of these three members of the Unilife executive team has more than 25 years of medical device and pharmaceutical experience in leadership roles for major multinational companies. To coincide with the appointment of Mr.Calvert, the CFO role in Australia became redundant. Former CFO Jeff Carter, however, continues to serve as a Director of the Board and as a consultant, where he is supporting Unilife’s corporate secretarial and ASX reporting requirements in Australia.

In the period between July 1, 2008 and October 1, 2009, Unilife has recruited a total of 47 staff, with more than 85 staff and full-time consultants now being employed worldwide. This includes the appointment of 35 management and professional personnel appointed at Unilife’s Lewisberry facility. Together the Unilife management team (below) has an average 23 years of experience working for a number of prominent multinational companies within the life science industry.